Can cryopreserved umbilical cord allograft improve post-RARP continence recovery?
October 29th 2020A new trial is exploring whether CLARIX CORD 1K, a cryopreserved umbilical cord allograft, can contribute to a faster return of erectile function and urinary continence after robot-assisted radical prostatectomy.
Radiotracer fluciclovine (18F) PET leads to improved cancer control in recurrent prostate cancer
October 27th 2020EMPIRE-1 is the first randomized trial to demonstrate an improvement in failure-free survival with treatment based on advanced molecular imaging versus conventional imaging in men with recurrent prostate cancer.
FDA grants nivolumab/cabozantinib combo priority review in kidney cancer
October 19th 2020The FDA is reviewing data from the phase 3 CheckMate-9ER trial, which showed that the combination significantly improved progression-free and overall survival compared with sunitinib in frontline renal cell carcinoma.
FDA issues draft guidance for adjuvant trials in bladder cancer, renal cell carcinoma
October 2nd 2020"Currently, there is significant variability in the design, conduct, and analysis of clinical trials for adjuvant treatment of both kidney cancer and bladder cancer. This variability negatively affects our ability to interpret trial results," said Richard Pazdur, MD.